3,4-dihydroxyphenylethanol has been researched along with acarbose in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, N; Liu, JP; Shi, YH; Sun, M; Wang, W; Wang, XP; Xie, YD; Xu, XY | 1 |
| Lee, SS; Lin, HC | 1 |
| Calcatierra, V; Fernández-Bolaños, JG; López, Ó; Padrón, JM; Plata, GB | 1 |
3 other study(ies) available for 3,4-dihydroxyphenylethanol and acarbose
| Article | Year |
|---|---|
3,4-Dihydroxyphenethyl nitrate with nitric oxide releasing, antioxidant, hypoglycemic and hypolipidemic effects.
Topics: Administration, Oral; Animals; Antioxidants; Diabetes Mellitus, Experimental; Hypoglycemic Agents; Hypolipidemic Agents; Mice; Molecular Structure; Nitrates; Nitric Oxide; Phenylethyl Alcohol; Streptozocin | 2020 |
Dibenzocycloheptanoids from the leaves of Cinnamomum subavenium.
Topics: Cinnamomum; Cycloheptanes; Geobacillus stearothermophilus; Glycoside Hydrolase Inhibitors; Glycosides; Inhibitory Concentration 50; Molecular Structure; Plant Leaves | 2012 |
Phenolic thio- and selenosemicarbazones as multi-target drugs.
Topics: alpha-Glucosidases; Antineoplastic Agents; Antioxidants; Cell Line, Tumor; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Glycoside Hydrolase Inhibitors; Humans; Hydrogen Peroxide; Lipid Peroxidation; Phenols; Semicarbazones; Structure-Activity Relationship; Sulfur Compounds | 2015 |